Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14, but Not with Loss-of-Function Mutations in IL36RN in European Patients

Journal of Investigative Dermatology

Volumn 135, Issue 10, 2015, Pages 2538-2541

  Mössner, Rotraut ^a   Frambach, Yvonne ^b,c   Wilsmann Theis, Dagmar ^d   Löhr, Sabine ^e   Jacobi, Arnd ^f,l   Weyergraf, Ansgar ^g   Müller, Michael ^a   Philipp, Sandra ^h   Renner, Regina ^e   Traupe, Heiko ⁱ   Burkhardt, Harald ^j   Kingo, Külli ^k   Kõks, Sulev ^k   Uebe, Steffen ^e   Sticherling, Michael ^e   Sticht, Heinrich ^e   Oji, Vinzenz ⁱ   Hüffmeier, Ulrike ^e  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c Hanse Klinik GmbH   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g Fachklinik Bad Bentheim   (Germany)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ UNIVERSITY OF MÜNSTER   (Germany)

^j GOETHE UNIVERSITY   (Germany)

^k UNIVERSITY OF TARTU   (Estonia)

^l PHILIPPS UNIVERSITY MARBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CARD14 GENE; CLINICAL FEATURE; CONTROLLED STUDY; EUROPEAN; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; IL36RN GENE; LETTER; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MISSENSE MUTATION; MUTATOR GENE; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS; AGED; COHORT ANALYSIS; COMPARATIVE STUDY; EUROPE; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; MASS SCREENING; PROCEDURES; PSORIASIS;

CARD14 PROTEIN, HUMAN; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; GUANYLATE CYCLASE; IL36RN PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; MEMBRANE PROTEIN;

ADULT; AGED; CARD SIGNALING ADAPTOR PROTEINS; COHORT STUDIES; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GUANYLATE CYCLASE; HUMANS; INCIDENCE; INTERLEUKINS; MALE; MASS SCREENING; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION, MISSENSE; PSORIASIS;

EID: 84941424371     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.186     Document Type: Letter

References (17)

1. Ammoury A, El Sayed F, Dhaybi R et al. (2008) Palmoplantar pustulosis should not be considered as a variant of psoriasis. J Eur Acad Dermatol Venereol 22: 392-3
2. Asumalahti K, Ameen M, Suomela S et al. (2003) Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Investig Dermatol Symp Proc 120: 627-32
3. Brunasso AM, Puntoni M, Aberer W et al. (2013) Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study. Br J Dermatol 168: 1243-51
4. De Mozzi P, Johnston GA, Alexandroff AB (2012) Psoriasis: an evidence-based update. Report of the 9th evidenced based update meeting, 12 May 2011, Loughborough, UK. Br J Dermatol 166: 252-60
5. Fan X, Yang S, Sun LD et al. (2007) Comparison of clinical features of HLA-Cw 0602-positive and-negative psoriasis patients in a Han Chinese population. Acta Dermato-venereol 87: 335-40
6. Genomes Project C, Abecasis GR, Altshuler D et al. (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-73
7. Huffmeier U, Lascorz J, Bohm B et al. (2009) Genetic variants of the IL-23 R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Investig Dermatol Symp Proc 129: 355-8
8. Jordan CT, Cao L, Roberson ED et al. (2012a) Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. AmJ Hum Genet 90: 796-808
9. Jordan CT, Cao L, Roberson ED et al. (2012b) PSORS2 is due to mutations in CARD14. AmJ Hum Genet 90: 784-95
10. Karvonen J, Tilikainen A, Lassus A (1976) HLA antigens in psoriasis. A family study. Ann Clin Res 8: 298-304
11. Korber A, Mossner R, Renner R et al. (2013) Mutations in IL36RN in patients with generalized pustular psoriasis. J Investig Dermatol Symp Proc 133: 2634-7
12. Marrakchi S, Guigue P, Renshaw BR et al. (2011) Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 365: 620-8
13. Marsland AM, Chalmers RJ, Hollis S et al. (2006) Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev (1) CD001433
14. O'Doherty CJ, MacIntyre C (1985) Palmoplantar pustulosis and smoking. Br Med J 291: 861-4
15. Onoufriadis A, Simpson MA, Pink AE et al. (2011) Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet 89: 432-7
16. Setta-Kaffetzi N, Navarini AA, Patel VM et al. (2013) Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes. J Investig Dermatol Symp Proc 133: 1366-9
17. Sugiura K, Muto M, Akiyama M (2014) CARD14 c. 526G4C (p. Asp176His) is a significant risk factor for generalized pustular psoriasis with psoriasis vulgaris in the Japanese cohort. J Investig Dermatol Symp Proc 134: 1755-7